THIS SHARE WILL BE WORTH 3.00 IN 2009

Yes I'm winding you up...

I suspect that broker has something to gain by bulling it up.

I cant ever see 1.00 as the take out price.

More like 65p - 70p at the best. IMHO

Don't usually put any price on an SP but I will be very surprised if the take out price is less than 1. My bet is 1.10p.

Personally I see this as MM having a smirk - almost any news of a bid ( in these days of low sp), means the Co has to issue an RNS - this causes puinters to look at their wallets, meanwhile the City has bought cheaply and will release the stock as the probability of a bid diminishes.

Let's face it, unless the Bid is serious about 1 then PTI Execs will reject it....where else could they find employment if they sold it cheap? - Furthermore they will miss out on the meetings/City-splendour and potential big-bucks "if" one of the Drugs actually works, as they hope.

What on earth would encourage them to sell out at 50p? - it's nearly that now AND they are receiving a very decent living. No, I can't see any BID (other than by the Execs themselves - in which case they should be dismissed without reward) - being successful unless it's 1. More, would be v. nice as others have wished.

Question is, what to do with the small profit I've made from a fortuitous purchase? It was just 2-weeks before the balloon went up.....sure I hold from earlier (higher), but a profit is a profit, they say, and I'm not used to it.

Agree re the bid less than 1 comment.
As to the bid itself, it is far passed a rumor stage when a company release an RNS stating, Protherics confirms it has received approaches from a number of parties interested in acquiring Protherics.
No doubt the sp will fluctuate over the next few weeks as if a firm bid was put in today (very doubtful re due diligence etc) the timescale is at least 2 months for finalization, so many who bought in lower than todays price will get impatient and take profits.
But at least we would get to know what any predators approx valuations are.
My betting is that the first firm offer will be at a discount to any final figure of at least 20%.
Like Hangon I am in at differing sp levels, (from 30p to 80p), so I will have to sell at minimum of 63p to make any profit.

Nice but very long article re the hunger of big pharmas re Mergers and Acquisitions.
Worth skimming through.

http://www.marketwatch.com/news/story/dealmaking-financing-mergers-acquisitions-pharmaceuticals/story.aspx?guid=%7B04B64222-C339-4D4E-9E8C-E3F650C66A10%7D&dist=hppr

Latest.
UK biotech company BTG have just been named as another possible suitor re protherics.
Protherics have also taken on Ashurst corporate partners Andrew Edge and Michael Johns who will be advising on the bids, along with IP partner Dominic Batchelor.

Also an interesting example re high prices being offered.
Oxford BioMedica has turned down takeover bids by the USAs GeneThera, a move which has sent its shares soaring and highlights the increased interest of late in biotechnology firms, especially British ones.

The Oxford-headquartered firm revealed that GeneThera, were willing to pay 0.35 per share more than......four times its closing price on Thursday....., when its value stood at 46.5 million.

4 or even 3 times the closing price of Protherics Wed close of 38p (pre RNS) would do me.

Sorry Duplicate Post.

Greekman- really!
...( answers to OXB++, on PTI-thread! Sorry)...
There is zero chance GeneThera will bid for OXB -with any hope of success!
GebeThera is a small Bio with hardly any cash and little turnover - Mkt cap is said to be well under $1m- OXB is a Full-List with abt. 50m cash ( That's about 200x the notional value of GeneThera ).
It's a bit like my local Chippy bidding for Macdonalds - it ain't gona happen... Quite why GeneThera sounded-off I don't know; but I'd welcome OXB taking them over...
+The rise in OXB sp is because our MM's think other punters will wake-up to OXB's hidden value.....the Trovax trials are not dead yet....so I topped up at 8p on the bad news a couple of months ago. Due to the falls OXB is no-longer my No1 holding...ahem. OXB trial results are looking dulled, so I don't think we'll see much sp movement - therefore MM's have to stir the pudding.


Protherics appears to be in BID situation, but so far we don't know who! I hope it's not Management - PTI has a decent pipeline, as well as the Rattlesnake product which sells and sells. Previously PTI could command 70p so, today it looks weak...despite the rise...
I can't see BTG being the suitor - they take products and bring them to Market, so if it was a license-deal that might be true....but a Bid?

As for Big Pharma wanting to takeover pipelines - there seems to be no evidence for it, although a few have happened - but no rush, is what I mean -- -some JV, like Sanofi with OXB but they appear to be willing to pay Royalties rather than bid big-cash in one go.
I guess it's cheaper to take smaller bites, which can be financed by Sales.

Any views on Vernalis[VER]-?

The link at post 263 shows some hunger for big pharma takeovers and there are many more articles stating that the pharma industry is the one that is at present possibly the most vulnerable sector to such takeovers.
As to BTG like you I think it doubtful, unless there is a big semi outside backer,(the ever present hedge fund or private backer syndicates could be sniffing around but although possible very doubtful). As to AstraZeneca and BTG they have now been named in several newspapers as possible suiters so I would have thought that they would have released a denial if there was no truth in either being interested. But perhaps I am reading it wrong.

Well we shall see greek man. I hope you are correct!!
Nice bounce following low turnover.

Morning Transco,

As you say a nice bounce back especially with the markets on both sides of the water having a bad day. I for one expected Protherics to finish down the way things were going so yes, only up a tad but nicely unexpected.

Lots of rule 8 releases coming through. Things being sorted as per LSE rules.

I was just thinking about topping up with the sp 5% down less than 15 mins ago when it suddenly plunged to 8% down and counting. Something has no doubt leaked as it did 2 weeks ago.
Looking scary to say the least. Although I still think that the current sp with or without a bid is a bargain, if the market does not agree, I will sit on the proverbial fence to see what crawls out. If that makes sense.

This could be the reason, although I would have thought this would have had all or most of an effect earlier.

FT Comment - Peel Hunt are repeating their scepticism about PTI expressed earlier in the year and at the time of the original announcement.


Doubts about Protherics' takeover talks sent the drugs developer lower by 5.1 per cent to 55p.

AstraZeneca and Nycomed have both been linked with Protherics, which admitted a fortnight ago to receiving approaches. But Paul Cuddon, analyst at KBC Peel Hunt, said AstraZeneca rarely risked buying companies with unproven drugs, while Nycomed had little strategic use for Protherics' cancer and cardiovascular treatments.

More likely, Mr Cuddon said, would be an all-share offer from a peer such as BTG , down 1.2 per cent to 225p. "If indeed a cash bid has been made in excess of our 29p target price, we would urge investors to accept," he said.

How the hell can they justify taking a bid as low as 29p.

Regarding the above. A post on another site has KBC shorting Protherics (anyone have a site that shows if this is correct).

I did wonder if they had an ulterior motive especially when Finncap analyst Keith Redpath has a 100 pence price target on the company, and Seymour who tend to be cautious have a target price of 67p.

Of course any innuendo of bent dealing must be wide of the mark as obviously the market and those who have their fingers in the pie so to speak are whiter than white due to their fear of the LSE and FSA. Aren't they.

Interesting comments Greekman - thanks. I'm still in profit with these but did get a bit nervous yesterday!

Looks like Barclays have a few shorts to cover, (RNS released 1350 hrs, but not on this site).

This does not look good - looks like a slow death.
Its anyones guess what the outcome will be but I don't like the look of the graph!!
PTI has a reputation for letting punter down!

The recent (fantastic!), rise was due to "Bid approach" - and naturally there is a period of excitement - But, slowly folks don't believe a bid will come. However, IF a bid came, it would be below the value the buyer places on the business . . . . so, what value do you think is here?

- - - - - - - - However, the company hasn't changed! - - - - - - - - -

If you liked it before, it's still OK.
FWIW I hold.

As there has been no offer made public yet, I can say with some certainty, it will be on Tuesday 23rd Sept. How do I know, because before the market opens on that day I will be on route to Egypt. The last 3 important milestones in my portfolio companies have all occurred when I have been out the loop so to speak.
Also on return from my last 5 holidays my portfolio has been down.
I am beginning to think it's a conspiracy.